Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7309 p104
24 July 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Spending boost will depend on public involvement

Government plans to boost NHS spending by 7.2 per cent above inflation for the next three years are dependent on the public taking an active role in preventing ill health, health economists have warned.

The spending plans, announced by Chancellor of the Exchequer Gordon Brown last week, also rely on an anticipated 2.5 per cent improvement in NHS productivity.

But independent health economists at the Office of Health Economics in their new publication, “How much should we be spending on the NHS?”, question how reliable the predictions are. They point out that the spending plans and economic forecast reflect the government-commissioned report by Derek Wanless, “Securing our future health: taking a long-term view”, which was published in April 2002.

The OHE wants to see public access to the economic models these assumptions were based on so that an open assessment can be made about how far the targets are being met.

Meanwhile, the Association of the British Pharmaceutical Industry has welcomed the Chancellor’s commitment to increase funding for science from £3.9bn to £5bn by 2008 and its decision to recruit more science teachers.

The ABPI director of science and technology Philip Wright said: “The extra money from the Government will go a long way to enabling the UK to retain its world-leading position in the field of science and pharmaceuticals.”

Back to Top


©The Pharmaceutical Journal